Oracle’s stock’s peak price was largely driven by the remaining performance obligations from Q1, which increased further to $523 billion in Q2. The problem is that the Q2 report says short-term deferred revenues were $9.9 billion. The 10-Q form says total deferred revenues are $11.175 billion.